Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Sale of 5,000 PBYI shares, $45.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale | 5,000 | $45.5K |
| Aug 24, 2026 | Kura Oncology, Inc. (KURA) | Purchase | 100,000 | $1.24M |
| Aug 17, 2026 | Kura Oncology, Inc. (KURA) | Purchase | 100,000 | $1.11M |
| Jun 16, 2026 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/Award | 27,000 | n/a |
| Mar 25, 2026 | Kura Oncology, Inc. (KURA) | Exercise/Conversion | 6,103 | $37.5K |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 65,091 | n/a |
| Jan 6, 2026 | Kura Oncology, Inc. (KURA) | Grant/Award | 1,120,000 | n/a |
| Nov 15, 2025 | Kura Oncology, Inc. (KURA) | Grant/Award | 182,500 | n/a |
| Sep 29, 2025 | Kura Oncology, Inc. (KURA) | Grant/Award | 182,500 | n/a |
| Sep 9, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 14,500 | $181.0K |